Lonza Group

Founded in 1897, Lonza is a global leader in the development and manufacturing of pharmaceuticals and biotechnology products. With its headquarters situated in Basel, Switzerland, Lonza has made significant strides in delivering innovative healthcare solutions, ensuring global accessibility and improving patient lives. Their expertise encompasses a wide range of services, cementing their reputation as a trusted partner in the life sciences sector.

Lonza's comprehensive offerings span across contract development and manufacturing, specialty chemicals, and microbial control solutions. They are at the forefront of advancements in cell and gene therapy, providing tailored solutions that meet the evolving demands of the healthcare industry. The company prides itself on leveraging cutting-edge technology and a robust scientific framework to deliver unparalleled quality and reliability in its services.

With a workforce comprising 18,000 dedicated employees, Lonza continues to drive innovation and excellence in its operations worldwide. The leadership under CEO Wolfgang Wienand underscores their commitment to fostering a culture of collaboration and sustainable growth. Lonza's strategic initiatives focus on expanding its global footprint, reinforcing its position as a pivotal player in the pharmaceutical and biotechnology landscape.